Verastem (VSTM)

[n3m3sis]

Thank you for that post Stockguard!

It was very informative and educational. However nowhere did I see the data on phase 2 or phase 3 trials on human patients. with primary endpoints met.
The conclusion was sound and for sure, more work needs to be done.

My point was that ordinarily VSTM would have hit $7-8 today and the reason it did not, was due to a hit piece that was put out there on Sunday with the express intention to cause to happen, what did happen today. I have seen it many times.... in fact it is happening still with another position that I am in. Nonetheless, the cream will always rise to the top.imo

I await the next quarter with great interest.

GLTY

n3m